An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats

被引：0
|
作者：
Takao Yoshimizu
Toshiharu Shimazaki
Akie Ito
Shigeyuki Chaki
机构：
[1] Taisho Pharmaceutical Co.,Psychiatric Diseases and Pain Research, Medicinal Pharmacology Laboratory, Medicinal Research Laboratories
[2] Ltd.,undefined
来源：
Psychopharmacology | 2006年 / 186卷
关键词：
mGluR2/3; Learned helplessness; Conditioned fear stress; Depression; Anxiety; MGS0039;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 43 条
  • [1] An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats
    Yoshimizu, Takao
    Shimazaki, Toshiharu
    Ito, Akie
    Chaki, Shigeyuki
    PSYCHOPHARMACOLOGY, 2006, 186 (04) : 587 - 593
  • [2] Antidepressant and anxiolytic effects of an mGlu2/3 receptor antagonist, MGS0039
    Ito, Akie
    Shimazaki, Toshiharu
    Yoshimizu, Takao
    Iijima, Michihiko
    Chaki, Shigeyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 232P - 232P
  • [3] Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
    Dong, Chao
    Zhang, Ji-chun
    Yao, Wei
    Ren, Qian
    Ma, Min
    Yang, Chun
    Chaki, Shigeyuki
    Hashimoto, Kenji
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2017, 20 (03): : 228 - 236
  • [4] A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell
    Karasawa, JI
    Yoshimizu, T
    Chaki, S
    NEUROSCIENCE LETTERS, 2006, 393 (2-3) : 127 - 130
  • [5] mTOR activation is required for the antidepressant effects of mGluR2/3 blockade
    Dwyer, Jason M.
    Lepack, Ashley E.
    Duman, Ronald S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (04): : 429 - 434
  • [6] Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): A potent and orally active group II mGluR antagonist with antidepressant-like potential
    Yasuhara, Akito
    Nakamura, Masato
    Sakagami, Kazunari
    Shimazaki, Toshiharu
    Yoshikawa, Ryoko
    Chaki, Shigeyuki
    Ohta, Hiroshi
    Nakazato, Atsuro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (12) : 4193 - 4207
  • [7] Pharmacological Modulation of Sleep Homeostasis in Rat: Novel Effects of an mGluR2/3 Antagonist
    Hanley, Nicola
    Paulissen, Jerome
    Eastwood, Brian J.
    Gilmour, Gary
    Loomis, Sally
    Wafford, Keith A.
    McCarthy, Andrew
    SLEEP, 2019, 42 (09)
  • [8] MEDI 474-Prodrugs of 3-(3,4-dicholorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): Potent and orally active group II mGluR antagonist with antidepressant-like potential
    Yasuhara, Akito
    Nakamura, Masato
    Sakagami, Kazunari
    Kawakita, Yasunori
    Shimazaki, Toshiharu
    Chaki, Shigeyuki
    Ohta, Hiroshi
    Nakazato, Atsuro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [9] Role of mGluR2/3 in the behavioral-stimulant effects of cocaine in squirrel monkeys
    Bauzo, Rayna M.
    Zhou, Mi
    Kimmel, Heather L.
    Howell, Leonard L.
    FASEB JOURNAL, 2007, 21 (06): : A777 - A778
  • [10] The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task
    Semenova, Svetlana
    Markou, Athina
    NEUROPHARMACOLOGY, 2007, 52 (03) : 863 - 872
12345